Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
| ▸ | ATM | Q13315 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | CA12 | O43570 | 2/20 | 0.40 |
| ▸ | CA1 | P00915 | 2/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.40 |
| ▸ | CA9 | Q16790 | 2/20 | 0.40 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.40 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.38 |
| ▸ | RELA | Q04206 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17655950 | 0.94 | ALDH1A1 (0.40) | KDM4EATML3MBTL1CA12CA1 | |
| SCHEMBL17655805 | 0.94 | ALDH1A1 (0.40) | KDM4EATML3MBTL1CA12CA1 | |
| SCHEMBL24154174 | 0.93 | CA12 (0.43) | KDM4EATML3MBTL1CA12CA1 | |
| SCHEMBL14749024 | 0.93 | KDM4E (0.41) | KDM4EATML3MBTL1CA12CA1 | |
| SCHEMBL17655945 | 0.93 | KDM4E (0.41) | KDM4EATML3MBTL1CA12CA1 | |
| SCHEMBL17943382 | 0.92 | KDM4E (0.46) | KDM4EATML3MBTL1CA12CA1 | |
| SCHEMBL25726596 | 0.91 | KDM4E (0.42) | KDM4EATML3MBTL1HSD17B1HSD17B2 | |
| SCHEMBL19276001 | 0.91 | KDM4E (0.47) | KDM4EATML3MBTL1CA12CA1 | |
| SCHEMBL24372640 | 0.90 | KDM4E (0.40) | KDM4EATML3MBTL1CA12CA1 | |
| SCHEMBL14749052 | 0.90 | KDM4E (0.41) | KDM4EATML3MBTL1CA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3002282-B1 | HETERO RING COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME | LG CHEMICAL LTD (KR) | 2019-01-02 | — | — | EP | disclosed |
| US-9882145-B2 | Hetero ring compound and organic light emitting diode comprising same | LG CHEM, LTD. (KR) | 2018-01-30 | — | — | US | disclosed |
| US-9882145-B2 | Hetero ring compound and organic light emitting diode comprising same | LG CHEM, LTD. (KR) | 2018-01-30 | — | — | US | disclosed |
| US-20160141514-A1 | HETERO RING COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME | LG CHEM, LTD. (KR) | 2016-05-19 | — | — | US | disclosed |
| US-20160141514-A1 | HETERO RING COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME | LG CHEM, LTD. (KR) | 2016-05-19 | — | — | US | disclosed |
| EP-3002282-A1 | HETERO RING COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME | LG Chem, Ltd. (KR) | 2016-04-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160141514-A1 | HETERO RING COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME | CRY1, CRY2, PER2 | KDM4E 2098/4885ATM 2997/4885L3MBTL1 28/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.